CVE-2025-31946

CVE-2025-31946 is a medium-severity vulnerability with a CVSS 3.x base score of 6.2. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-416.

Key facts

Description

Pixmeo OsiriX MD is vulnerable to a local use after free scenario, which could allow an attacker to locally import a crafted DICOM file and cause memory corruption or a system crash.

Frequently asked questions

What is CVE-2025-31946?
Pixmeo OsiriX MD is vulnerable to a local use after free scenario, which could allow an attacker to locally import a crafted DICOM file and cause memory corruption or a system crash.
How severe is CVE-2025-31946?
CVE-2025-31946 has a CVSS 3.x base score of 6.2, rated medium severity. It is exploitable over local access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity none, and availability high.
Is CVE-2025-31946 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (16th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2025-31946?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-31946 have an EU (EUVD) identifier?
Yes. CVE-2025-31946 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-14718.
When was CVE-2025-31946 published?
CVE-2025-31946 was published on 2025-05-08 and last updated on 2026-06-17.

References

Other CWE-416 (Use After Free) vulnerabilities

Browse all CWE-416 (Use After Free) vulnerabilities →